Ligand · D17
D17 · N-({3-[({4-[(Z)-(4-oxo-2-thioxo-1,3-thiazolidin-5-ylidene)methyl]phenyl}amino)methyl]phenyl}carbonyl)-L-glutamic acid
D17, N-({3-[({4-[(Z)-(4-oxo-2-thioxo-1,3-thiazolidin-5-ylidene)methyl]phenyl}amino)methyl]phenyl}carbonyl)-L-glutamic acid (C23 H21 N3 O6 S2, 499.6 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every…
- Component
- D17
- Formula
- C23 H21 N3 O6 S2
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
D17 in 2 structures; the first of them:
- 2WJP · Crystal structure of murd ligase in complex with D-glu containing rhodanine inhibitor · D17 A1441 · binds ILE11, GLY12, ASP35, THR36, ARG37, SER71, PRO72, GLY73 and 11 more
- 2WJP · Crystal structure of murd ligase in complex with D-glu containing rhodanine inhibitor · D17 A1441 · binds ILE11, GLY12, ASP35, THR36, ARG37, SER71, PRO72, GLY73 and 11 more
Residues it binds most
ARG 2, GLY 2, ILE 2, PHE 2, SER 2, THR 2, ALA 2, ASN 2, ASP 2, HIS 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.